Specific Graft Treatment Solution Enhances Vascular Endothelial Function.

BACKGROUND

Saline is still the most widely used storage and rinsing solution for vessel grafts during cardiac surgery despite knowing evidence of its negative influence on the human endothelial cell function. Aim of this study was to assess the effect of DuraGraft©, an intraoperative graft treatment solution, on human saphenous vein segments and further elaborate the vasoprotective effect on rat aortic segments in comparison to saline.

METHODS

Human Saphenous vein (HSV) graft segments from patients undergoing aortocoronary bypass surgery (n = 15), were randomized to DuraGraft© (n = 15) or saline (n = 15) solution before intraoperative storage. Each segment was divided into two subsegmental parts for evaluation. These segments as well as rat aortic segments stored in DuraGraft© underwent assessment of vascular function in a multichamber isometric myograph system in comparison to Krebs-Henseleit solution (KHS), a physiologic organ buffer solution.

RESULTS

Potassium-Chloride (KCL)-induced contraction depicted a tendency towards increase when treated with DuraGraft© compared to saline preservation of HSV segments (23.02 14.77 vs 14.44 9.13 mN, = 0.0571). Vein segments preserved with DuraGraft© showed a significant improvement of endothelium-dependent vasorelaxation in response to cumulative concentrations of bradykinin compared to saline treated segments ( 0.05). Rat aortic segments stored in saline showed significantly impaired vasoconstriction (3.59 4.20, 0.0001) and vasorelaxation when compared to KHS and DuraGraft© ( 0.0001).

CONCLUSIONS

DuraGraft© demonstrated a favorable effect on graft relaxation and contraction indicating preservation of vascular endothelial function.

CLINICAL TRIAL REGISTRATION NUMBER

NCT04614077.